Cancer Drug

Swiss pharmaceuticals giant Novartis headquarter building is pictured in Basel. (credit: Getty Images/Sebastien Bozon/AFP)

Bone Drug Zometa Flops In Breast Cancer Study

One of the most promising new approaches for fighting breast cancer took a stunning setback Thursday when a major study showed that a bone-building drug did not stop cancer from returning or extend life.